According to the latest monthly return, Mabpharm Limited (02181) reported no changes in its authorised share capital, remaining at US$5,000,000. As of January 31, 2026, the company’s total issued share count was 4,124,080,000 ordinary shares, with no treasury shares reported. The company affirmed that it meets the public float requirement of 25%.

In its share option scheme, 72,670,876 options remained outstanding and no new shares were issued pursuant to option exercises. The scheme received general meeting approval on August 10, 2018 and had no changes during the reporting month.